Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
about
Physiological and morphological effects of genistein against the liver fluke, Fasciola hepaticaA scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica.A transmission electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica.Testing albendazole resistance in Fasciola hepatica: validation of an egg hatch test with isolates from South America and the United Kingdom.Fasciola hepatica: Histology of the Reproductive Organs and Differential Effects of Triclabendazole on Drug-Sensitive and Drug-Resistant Fluke Isolates and on Flukes from Selected Field CasesTranscriptome profiling of gene expression during immunisation trial against Fasciola hepatica: identification of genes and pathways involved in conferring immunoprotection in a murine modelTriclabendazole progress report, 2005-2009: an advancement of learning?In vitro and in vivo trematode models for chemotherapeutic studies.Current status of food-borne trematode infections.Microtubules as antiparasitic drug targets.Electron microscopical study to assess the in vitro effects of the synthetic trioxolane OZ78 against the liver fluke, Fasciola hepatica.Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.Erratum to: inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha.Pharmacokinetic behavior in sheep and cattle of 5-chloro-2-(methylthio)-6-(1-naphthyloxy)-1H-benzimidazole, a new fasciolicide agent.
P2860
Q28292996-CCF064D1-CD0A-42F6-9234-DA0419B13781Q33416221-B7D78EFB-1D29-4475-A49B-301B1EF18FEEQ33520555-9690550B-B9A2-482C-AB31-D01F5739D1EAQ34627791-C4DA15DA-02D7-4ACC-B77B-EB851BA0E5DDQ36096359-DFCEC44D-CE71-44F6-88A1-840360E96D80Q36257836-3822645C-D5B5-472D-ACED-B8F6560BBE1FQ37444251-F0099527-ECBF-4879-8319-FD2AAD4A325AQ37644571-09385606-43F6-4E5D-AC36-AB9D43B7D855Q37974131-882E3BEC-811C-487B-AC38-F06C50B9DDD0Q39002137-47E5C1BD-2749-431C-BD7B-BB490D0F8614Q42458074-5E2672CE-1794-40C7-9C69-53CD3AF32401Q42485937-1AA38809-C7D9-4DD1-9155-87D2E4DEE0B8Q42493268-C69F149A-BC46-4004-AD82-3786E7CFFEC9Q46050145-D10D06F5-313C-4870-A0C1-2740E3ADBBC3Q46086267-38831696-3845-4BAE-B957-ED9662B9E67B
P2860
Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Adult triclabendazole-resistan ...... l fasciolicide compound alpha.
@en
Adult triclabendazole-resistan ...... l fasciolicide compound alpha.
@nl
type
label
Adult triclabendazole-resistan ...... l fasciolicide compound alpha.
@en
Adult triclabendazole-resistan ...... l fasciolicide compound alpha.
@nl
prefLabel
Adult triclabendazole-resistan ...... l fasciolicide compound alpha.
@en
Adult triclabendazole-resistan ...... l fasciolicide compound alpha.
@nl
P2093
P2860
P1433
P1476
Adult triclabendazole-resistan ...... l fasciolicide compound alpha.
@en
P2093
Brennan GP
Castillo R
Fairweather I
Hernandez-Campos A
McConville M
P2860
P304
P356
10.1017/S0031182006000114
P577
2006-05-02T00:00:00Z